These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38289166)

  • 1. Effectiveness of opioid maintenance programs for treating drug dependence in prisons.
    Roselló-Jordá S; Espinós-Navarro C; Molés-Julio MP
    Rev Esp Sanid Penit; 2023; 25(3):112-121. PubMed ID: 38289166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid agonist treatment for pharmaceutical opioid dependent people.
    Nielsen S; Larance B; Degenhardt L; Gowing L; Kehler C; Lintzeris N
    Cochrane Database Syst Rev; 2016 May; (5):CD011117. PubMed ID: 27157143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance agonist treatments for opiate-dependent pregnant women.
    Minozzi S; Amato L; Jahanfar S; Bellisario C; Ferri M; Davoli M
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006318. PubMed ID: 33165953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2002; (4):CD002207. PubMed ID: 12519569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2004; (3):CD002207. PubMed ID: 15266465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2003; (2):CD002207. PubMed ID: 12804429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence.
    Simoens S; Matheson C; Bond C; Inkster K; Ludbrook A
    Br J Gen Pract; 2005 Feb; 55(511):139-46. PubMed ID: 15720937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription opioid abuse in prison settings: A systematic review of prevalence, practice and treatment responses.
    Bi-Mohammed Z; Wright NM; Hearty P; King N; Gavin H
    Drug Alcohol Depend; 2017 Feb; 171():122-131. PubMed ID: 28086177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Opioid Substitution Treatment in Prisons: Comparison of Cost of Buprenorphine Depot with other Medications - a Health-Economic Calculation].
    Stöver H; Keppler K
    Gesundheitswesen; 2023 Jun; 85(6):573-577. PubMed ID: 35921849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of attitudes toward opioid agonist treatment among short-term buprenorphine patients.
    Kelly SM; Brown BS; Katz EC; O'Grady KE; Mitchell SG; King S; Schwartz RP
    Am J Drug Alcohol Abuse; 2012 May; 38(3):233-8. PubMed ID: 22242643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition from methadone to subcutaneous buprenorphine depot in patients with opioid use disorder in custodial setting - a case series.
    Soyka M; Groß G
    Am J Drug Alcohol Abuse; 2021 Sep; 47(5):599-604. PubMed ID: 34407703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review.
    Moore KE; Roberts W; Reid HH; Smith KMZ; Oberleitner LMS; McKee SA
    J Subst Abuse Treat; 2019 Apr; 99():32-43. PubMed ID: 30797392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance treatments for opiate -dependent adolescents.
    Minozzi S; Amato L; Bellisario C; Davoli M
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD007210. PubMed ID: 24957634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study.
    Meyer MC; Johnston AM; Crocker AM; Heil SH
    J Addict Med; 2015; 9(2):81-6. PubMed ID: 25622120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of opioid agonist treatment prescribing in provincial prisons in Ontario, Canada, 2015-2018: a repeated cross-sectional analysis.
    Bodkin C; Bondy S; Regenstreif L; Kiefer L; Kouyoumdjian F
    BMJ Open; 2021 Nov; 11(11):e048944. PubMed ID: 34794988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2008 Apr; (2):CD002207. PubMed ID: 18425880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) Prisons Project Study: protocol for a randomised controlled trial comparing methadone and buprenorphine for opiate detoxification.
    Sheard L; Wright NM; Adams CE; Bound N; Rushforth B; Hart R; Tompkins CN
    Trials; 2009 Jul; 10():53. PubMed ID: 19602218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heroin anticraving medications: a systematic review.
    Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K
    Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use and misuse of opioid agonists in opioid addiction.
    Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
    Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia.
    Vijay A; Bazazi AR; Yee I; Kamarulzaman A; Altice FL
    J Subst Abuse Treat; 2015 Jul; 54():29-36. PubMed ID: 25841703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.